SIPMeL
Italian Society for Clinical Pathology and Laboratory Medicine
5 Recommendations on GREEN LABORATORY
released: 1 October 2025
last updated: 1 October 2025
How this list was created
The recommendations concerning the Green Laboratory (GL) were prepared by a narrow working group (NWG) of GL experts from the EBLM Working Group, which had organized events and manuscripts on the topic during the 2023 National Congress. On May 21, 2024, during a Zoom meeting of the EBLM Working Group, the NWG presented an initial list of recommendations, which were subsequently reduced to seven on July 2, 2024, during another Zoom meeting of the group. In August 2024, through extensive email exchanges, the NWG identified the five most relevant, current, and “sustainable” recommendations for clinical laboratories. These were approved by all members of the Working Group and by the President of SIPMeL. The final list of five recommendations for the Green Lab was presented at the 2024 National Congress and was later endorsed by the steering committee of Choosing Wisely Italy and by the SIPMeL National Council.
5 recommendations - second list from EVIDENCE BASED LABORATORY Medicine Study Group
released: 1 September 2023
last updated: 1 September 2023
How this list was created
An article by SIPMeL’s EBLM Working Group (WG) accessible online to all the association members (Riv Ital Med Lab 2022;7:7-10) proposed five new “procedures at greatest risk of inappropriateness” that were presented in a joint session with Choosing Wisely Italy at the 7th SIPMeL National Congress. The final list was approved after discussion at the session. In July 2023, an article by the EBLM WG containing a critical evaluation of the available relevant literature and the rationale supporting the inclusion of the individual recommendations was sent, after approval by the National President of SIPMeL, to La Rivista italiana della Medicina di Laboratorio.
5 recommendations from AUTOIMMUNOLOGY Study Group
released: 1 November 2018
last updated: 1 October 2025
How this list was created
The SIPMeL Study Group on Autoimmunology (GdS-AI) reviewed the five procedures at greatest risk of inappropriateness in the field of laboratory autoimmune diagnostics that had been first produced by the GdS-AI in 2018. The review of the proposals took place in a consensus conference organized in Florence in March 2025. Of the five proposals presented in 2018, the first two were merged into a single recommendation, two were confirmed and two new ones were inserted.
5 recommendations - first list from EVIDENCE BASED LABORATORY Medicine Study Group
released: 1 April 2017
last updated: 1 September 2023
How this list was created
In 2015 at the 1st SIPMeL National Congress, a working group developed a proposal for a list of the five procedures with the highest risk of inappropriateness. The list was discussed and approved. In the following months additional comments and proposals were gathered; no procedure reached greater consensus than the five originally listed. The National Council approved them. In 2023, the EBLM Working Group (WG) of SIPMeL was tasked to evaluate whether the first 5 SIPMeL recommendations of 2017 were still valid and, if they were, to update the bibliography. The WG proceeded with the update; the updated list was approved by the National President on June 15, 2023 and was sent to Choosing Wisely for evaluation.
5 recommendations from ENDOCRINOLOGY AND METABOLIC DISEASES Study Group
released: 1 November 2016
last updated: 1 May 2024
How this list was created
SIPMeL Endocrinology and Metabolic Diseases Study Group (SG-EMD) edited the list of five practices at risk of inappropriateness issued in October 2016 and updated in 2018. All members of the SG assessed the timeliness of the recommendations starting at the 20 October 2023 meeting. A select group took charge of checking whether more current and relevant articles had been published between 2016 and 2023 and prepared a document to which the entire SG contributed. The final list of five updated recommendations was approved by all SG-EMD members, the president of SIPMeL and the steering group of Choosing Wisely Italy.
About this society:
The Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) is a national medical/scientific association of professionals working in clinical laboratories. SIPMeL was established in 2014, as a reunification of SIMeL (Italian Society of Laboratory Medicine), founded in 1986, and AIPaCMeM (Italian Association of Clinical Pathology and Molecular Medicine), historical continuity of the Italian Association of Analysts and Pathologists (founded in 1947) and the Italian Society of Clinical Pathology operating since 1970. The structure of the society, which has about 2000 members, is federal and includes three professional components: doctors, graduates specialized in scientific disciplines (DSLB) and biomedical laboratory technicians (STLB). It is the task of the Society to develop and disseminate the professional standards on which “good practice” in the laboratory depends. The training activities recognize training credits to participants, in accordance with the Continuing Medical Education Program of the Ministry of Health. Scientific research and training production activities are promoted and maintained by 22 study groups.
Recent Comments